Intuitive Surgical, Inc. logo
Intuitive Surgical, Inc. (ISRG)
Compare

Intuitive Surgical, Inc. (ISRG) Revenue CAGR:21.44%(TTM)

Compare

The revenue cagr for Intuitive Surgical, Inc. (ISRG) is +21.44% over the latest trailing 12-month period. Revenue CAGR uses precomputed financial statement history.

The revenue cagr for Intuitive Surgical, Inc. (ISRG) stock is 21.44% over the past 12 months. The 3 year average growth rate is 18.06% and the 5 year cagr is 18.39%. Revenue CAGR measures how Intuitive Surgical, Inc.'s top-line revenue has grown over time. Consistent revenue growth is a key indicator of business expansion and market share gains.

ISRG Revenue CAGR Chart

Intuitive Surgical, Inc. (ISRG)

ISRG Revenue CAGR History

YearStart RevenueEnd RevenueChange% ChangeCAGR
2025$8.35B$10.06B+$1.71B+20.51%+20.51%
2024$7.12B$8.35B+$1.23B+17.24%+17.24%
2023$6.22B$7.12B+$901.90M+14.49%+14.49%
2022$5.71B$6.22B+$512.10M+8.97%+8.97%
2021$4.36B$5.71B+$1.35B+31.01%+31.01%
2020$4.48B$4.36B$-120.10M-2.68%-2.68%
2019$3.72B$4.48B+$754.30M+20.25%+20.25%
2018$3.13B$3.72B+$595.30M+19.03%+19.03%
2017$2.70B$3.13B+$424.50M+15.70%+15.70%
2016$2.38B$2.70B+$320.00M+13.42%+13.42%
2015$2.13B$2.38B+$252.70M+11.85%+11.85%
2014$2.27B$2.13B$-133.40M-5.89%-5.89%
2013$2.18B$2.27B+$86.30M+3.96%+3.96%
2012$1.76B$2.18B+$421.50M+23.99%+23.99%
2011$1.41B$1.76B+$344.30M+24.37%+24.37%
2010$1.05B$1.41B+$360.83M+34.29%+34.29%
2009$874.92M$1.05B+$177.25M+20.26%+20.26%
2008$600.83M$874.92M+$274.09M+45.62%+45.62%
2007$372.68M$600.83M+$228.15M+61.22%+61.22%
2006$227.34M$372.68M+$145.34M+63.93%+63.93%
2005$138.80M$227.34M+$88.53M+63.78%+63.78%
2004$91.67M$138.80M+$47.13M+51.41%+51.41%
2003$72.02M$91.67M+$19.65M+27.29%+27.29%
2002$51.67M$72.02M+$20.35M+39.38%+39.38%
2001$26.62M$51.67M+$25.05M+94.08%+94.08%
2000$10.19M$26.62M+$16.43M+161.22%+161.22%

Quarterly Revenue — QoQ & YoY

QuarterValueQoQYoY
Q1 2026$2.77B-3.3%+23.0%
Q4 2025$2.87B+14.4%+18.8%
Q3 2025$2.51B+2.7%+22.9%
Q2 2025$2.44B+8.3%+21.4%
Q1 2025$2.25B-6.6%+19.2%
Q4 2024$2.41B+18.4%+25.2%
Q3 2024$2.04B+1.4%+16.9%
Q2 2024$2.01B+6.3%+14.5%
Q1 2024$1.89B-2.0%+11.5%
Q4 2023$1.93B+10.6%+16.5%
Q3 2023$1.74B-0.7%+12.0%
Q2 2023$1.76B+3.5%+15.4%
Q1 2023$1.70B+2.5%+14.0%
Q4 2022$1.66B+6.3%+6.7%
Q3 2022$1.56B+2.3%+11.0%
Q2 2022$1.52B+2.3%+4.0%

QoQ = change vs the prior quarter; YoY = change vs the same quarter a year earlier.

About Intuitive Surgical, Inc.

Intuitive Surgical, Inc. is a leading medical technology firm dedicated to advancing patient care by developing, producing, and commercializing sophisticated tools. These innovations empower medical professionals to deliver superior, accessible, and less-invasive treatment options to patients both within the United States and across international markets. Its flagship offering, the da Vinci Surgical System, facilitates intricate operations through a minimally disruptive approach. Expanding beyond surgical applications, the company also provides the Ion endoluminal system, designed for diagnostic interventions like minimally invasive lung biopsies. Complementing its primary systems, Intuitive Surgical supplies a comprehensive array of instruments, including stapling tools, energy devices, and essential core components. Furthermore, it offers structured training programs to ensure proficient use of its technology, alongside extensive customer support services encompassing installation, repairs, and ongoing maintenance. The firm also integrates digital capabilities to deliver unified, connected solutions that optimize hospital performance through actionable insights. Established in 1995, Intuitive Surgical maintains its corporate headquarters in Sunnyvale, California.

Sunnyvale, CA
15,638 employees
Healthcare / Medical - Devices
Sector
Healthcare
Industry
Medical - Devices
CEO
David J. Rosa